Evidence for a mammalian late-G1 phase inhibitor of replication licensing distinct from geminin or Cdk activity

Takayo Sasaki1, Anatoliy Li, Peter J Gillespie

  • 1Department of Biological Science, Florida State University, Tallahassee, FL, USA.

Nucleus (Austin, Tex.)
|October 11, 2011
PubMed

Insights

Replication licensing is blocked before S phase entry by a novel inhibitor, distinct from geminin or Cdk. This finding clarifies cell cycle control and prevents DNA re-replication.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • DNA replication origin licensing by pre-replication complexes (pre-RCs) occurs in late mitosis and G1.
  • Preventing DNA re-replication requires shutting down licensing before S phase entry.

Purpose of the Study:

  • To investigate mechanisms that prevent replication licensing during late G1 phase.
  • To identify novel inhibitors of DNA replication licensing.

Main Methods:

  • Utilized a hybrid mammalian/Xenopus egg extract system.
  • Analyzed cell cycle stages of Chinese Hamster Ovary (CHO) cells.

Main Results:

  • Mitotic extracts inhibit licensing via geminin and Cdk; S-phase extracts use geminin.
  • A novel licensing inhibitor, independent of geminin and Cdk, appears in late G1/early S phase.
  • Inhibiting cyclin/geminin synthesis or Cdk activity in early G1 did not prevent inhibitor appearance.

Conclusions:

  • A soluble inhibitor, distinct from geminin or Cdk, emerges before S phase entry.
  • The hybrid system facilitates identification of novel cell cycle regulators.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.